1US Departmentof Healthand Human Services Monograph，1996年，30页
2Hatanaka K，Pathol Int，1995年，45卷，631页
3Liuzzo G，New Engl J Med，1994年，331卷，417页
4National Heart,Lung,and Blood Institute Fact Book. Fiscal Year 1995. US Department of Heart and Human Service Monogragh. March,1996:30～52
5Farmer JA,Gotto AM Jr. Dyslipidemia and other risk factors for coronary artery disease. In:Braunwald E,editor. Heart Disease:A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia:Saunders,1997.1126～1160
6Robinson K, Mayer EL,Miller DP,et al. Hyperhomocysteinemia and low pyridoxal phospate:common and independent reversible risk factors for coronary artery disease. Circulation, 1995,92:2825～2830
7Ross R. Ceel biology of atherosclerosis. Annu Rev Physiol, 1995,57:791～804
8Van der Wal AC,Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammation process irrespective of the dominant plaque morphology. Circulation, 1994,89:36～44
9Shah PK,Falk E,Badimon JJ,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques:potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation, 1995,92:1565～1569
10Maseri A. Inflammation,atherosclerosis,and ischemic events-exploring the hidden side of the moon. N Engl J Med, 1997,336:1014～1016
3Mouridsen MR.,Intzilakis T, Binici Z, et al. Prognostic value of high sensitive C-reactive protein in subjects with silent myocardial schemia [J]. JElectrocardiol, 2012, 45(3): 260-264.
